» Articles » PMID: 38577277

The Cost-effectiveness of Syphilis Screening in Pregnant Women: a Systematic Literature Review

Overview
Specialty Public Health
Date 2024 Apr 5
PMID 38577277
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The cost-effectiveness study of syphilis screening in pregnant women has not been synthesized. This study aimed to synthesize the economic evidence on the cost-effectiveness of syphilis screening in pregnant women that might contribute to making recommendations on the future direction of syphilis screening approaches.

Methods: We systematically searched MEDLINE, PubMed, and Web of Science databases for relevant studies published before 19 January 2023 and identified the cost-effectiveness analyses for syphilis screening in pregnant women. The methodological design quality was appraised by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 checklist.

Results: In total, 17 literature met the eligibility criteria for a full review. Of the 17 studies, four evaluated interventions using different screening methods, seven assessed a combination of syphilis testing and treatment interventions, three focused on repeat screening intervention, and four evaluated the interventions that integrated syphilis and HIV testing. The most cost-effective strategy appeared to be rapid syphilis testing with high treatment rates in pregnant women who were positive.

Discussion: The cost-effectiveness of syphilis screening for pregnancy has been widely demonstrated. It is very essential to improve the compliance with maternal screening and the treatment rates for positive pregnant women while implementing screening.

Citing Articles

The rise of congenital syphilis in Canada: threats and opportunities.

Tetteh A, Moore V Front Public Health. 2025; 12:1522698.

PMID: 39911782 PMC: 11794269. DOI: 10.3389/fpubh.2024.1522698.

References
1.
Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

2.
Korenromp E, Rowley J, Alonso M, Mello M, Wijesooriya N, Mahiane S . Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019; 14(2):e0211720. PMC: 6392238. DOI: 10.1371/journal.pone.0211720. View

3.
Gomez G, Kamb M, Newman L, Mark J, Broutet N, Hawkes S . Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013; 91(3):217-26. PMC: 3590617. DOI: 10.2471/BLT.12.107623. View

4.
Schackman B, Neukermans C, Fontain S, Nolte C, Joseph P, Pape J . Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med. 2007; 4(5):e183. PMC: 1880854. DOI: 10.1371/journal.pmed.0040183. View

5.
Wu M, Moore A, Seel M, Britton S, Dean J, Sharpe J . Congenital syphilis on the rise: the importance of testing and recognition. Med J Aust. 2021; 215(8):345-346.e1. DOI: 10.5694/mja2.51270. View